Achieve Life Sciences

Yahoo Finance • 4 days ago

Achieve Life Sciences Announces Publication in Thorax of Data Demonstrating Cytisinicline’s Potential Efficacy and Tolerability for Smoking Cessation in Individuals with COPD

SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 8 days ago

Achieve Life Sciences Promotes Craig Donnelly to Chief Operations Officer

SEATTLE and VANCOUVER, British Columbia, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 14 days ago

Achieve Life Sciences gets new interim chief medical officer

* Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]) said that [https://seekingalpha.com/pr/20230175-achieve-life-sciences-names-dr-mark-rubinstein-interim-chief-medical-officer] Mark Rubinstein, M.D., will assume... Full story

Yahoo Finance • 15 days ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • 24 days ago

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisiniclin... Full story

Yahoo Finance • last month

Which stocks are moving before the opening bell on Monday?

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses. [premarket] PRE-MARKET GAINERS TICKER CHANGE COMMENT O... Full story

Yahoo Finance • 2 months ago

Achieve Life Sciences Inc (NASDAQ:ACHV) Reports Q2 2025 Results: Revenue in Line, Narrow EPS Beat Drives Pre-Market Gains

Achieve Life Sciences Inc (NASDAQ:ACHV [https://www.chartmill.com/stock/quote/ACHV/profile]) reported its second-quarter 2025 financial results, posting revenue of $0.0 and an earnings per share (EPS) loss of $0.37. These figures were larg... Full story

Yahoo Finance • 2 months ago

Achieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference

SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 3 months ago

Should You Hold Achieve Life Sciences (ACHV)?

Rogue Funds, an investment management company, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund depreciated 12.4% net of fees in the quarter. The firm anticipates significant volatility... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters’ Option to Purchase Additional Securities

SEATTLE and VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences partners with Omnicom for product launch

[Cigarette with prohibition sign on wooden table, top view. Quitting smoking concept] Liudmila Chernetska/iStock via Getty Images * Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]) said that it has named Omnico... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences stock falls after pricing capital raise of $45M via securities offering

Achieve Life Sciences (NASDAQ:ACHV [https://seekingalpha.com/symbol/ACHV]) has announced the pricing of an underwritten public offering [https://seekingalpha.com/pr/20150242-achieve-life-sciences-announces-pricing-of-45_0-million-underwrit... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences Announces Pricing of $45.0 Million Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences names Omnicom as strategic partner for launch

SEATTLE/VANCOUVER - Achieve Life Sciences, Inc. (NASDAQ:ACHV) has appointed Omnicom (NYSE:OMC) as its strategic innovation partner and agency of record to support the planned U.S. commercial launch of cytisinicline, a treatment for nicotin... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences announces public offering to fund cytisinicline

SEATTLE/VANCOUVER - Achieve Life Sciences, Inc. (NASDAQ:ACHV), a $120.7 million market cap pharmaceutical company whose stock has shown strong momentum with a 21% gain over the past week, announced Thursday a proposed underwritten public o... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences Announces Proposed Underwritten Public Offering

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences Announces Partnership with Omnicom to Execute Integrated, Data-Driven Launch of the First Potential New Treatment for Nicotine Dependence in Nearly Two Decades

Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to enable a faster, smarter, and more effective path to addre... Full story

Yahoo Finance • 3 months ago

Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation

Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone If approved, cytisinicline will be the first new FDA-approved pharmacotherapy option for nicotine dependence in tw... Full story

Yahoo Finance • 4 months ago

Achieve Life Sciences to Present at the Jefferies Global Healthcare Conference

SEATTLE and VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline... Full story

Yahoo Finance • 4 months ago

Achieve Life Sciences Reports First Quarter 2025 Financial Results and Highlights Updates in Cytisinicline Program

Reiterates Planned Submission of an NDA for Cytisinicline to FDA in June 2025 Company to Host Conference Call at 8:30 AM EDT Today, Tuesday, May 13, 2025 SEATTLE and VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Achieve... Full story